Search

everythinglearnresearchcommunity

for

Search:↓

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Male pattern baldness may be linked to prostate cancer risk.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Dutasteride is effective for treating hair loss.

Treatments for hair loss vary, but cell-based options may be the future.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Finasteride, a hair loss treatment, may cause long-term sexual dysfunction and depression.

Finasteride for hair loss increases risk of sexual dysfunction in young men.

Hair loss and excessive growth treated with various options, including new laser technology.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Low-level laser therapy may help treat hair loss with fewer side effects.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride effectively treats male pattern hair loss by promoting hair growth and density.